Bristol-Myers Squibb (BMY) Announces Long-Term Survival Results from Opdivo in Lung Cancer

April 2, 2019 1:03 PM
Bristol-Myers Squibb Company (NYSE: BMY) today announced results from pooled analyses of survival data ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA

Next Articles